Summary
In insulin-deficient streptozotocin-treated rats the intestine is hypertrophic and cholesterol synthesis and transport from the intestine are increased. The increased load of cholesterol is transported through the mesenteric lymph in chylomicrons. Clearance from plasma of injected chylomicrons is slowed in insulin-deficient rats, but the underlying mechanisms are currently unresolved. Hyperphagia may increase the size of chylomicrons which could contribute to defective chylomicron clearance in insulin-deficiency. In the present experiments we compared the size and number of chylomicrons in mesenteric lymph of control rats and diabetic rats infused with fat at two levels. In control and diabetic lymph-cannulated rats, as the infused dose of lipid increased the transport of triglyceride increased substantially compared with fasted rats. In contrast the transport of apoB48 increased by only a small amount during fat transport. Therefore, increased lipid transport was accomplished mostly by increased particle size, with only small increases in numbers of particles in intestinal lymph. Insulin-deficiency had no effect on triglyceride or apoB48 transport in lymph. Calculations suggested that each chylomicron particle contained a single molecule of apoB48. When hyperphagia in diabetic rats was prevented, the plasma triglycerides were decreased but the slow plasma clearance of injected chylomicron-like emulsions persisted. Hyperphagia, therefore, was unconnected to the impairment in chylomicron metabolism in insulin-deficient rats. Changes in the association with plasma apolipoproteins, in the expression of receptors for uptake of chylomicron remnants or in exposure to endothelial lipases may be responsible for the defective clearance of triacylglycerol-rich lipoproteins.
Article PDF
Similar content being viewed by others
Abbreviations
- Apo:
-
Apolipoprotein
References
Chen S-H, Habib G, Yang CY et al. (1987) Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. Science 238: 363–366
Hodges P, Scott J (1992) Apolipoprotein B mRNA editing: a new tier for the control of gene expression. Trends Biochem Sci 17: 77–81
Powell LM, Wallis SC, Pease RJ, Edwards YH, Knott TJ, Scott J (1987) A novel form of tissue specific RNA processing produces apo-B48 in intestine. Cell 50: 831–840
Glickman RM, Rogers M, Glickman JN (1986) Apolipoprotein B synthesis by human liver and intestine in vitro. Proc Natl Acad Sci USA 83: 5296–5300
Hoeg JM, Sviridov DD, Tennyson GE et al. (1990) Both apolipoprotein B-48 and B-100 are synthesized and secreted by the human intestine. J Lipid Res 31: 1761–1769
Tennyson GE, Sabatos CA, Higuchi K, Meglin N, Brewer HB Jr (1989) Expression of apolipoprotein B mRNAs encoding higher- and lower-molecular weight isoproteins in rat liver and intestine. Proc Natl Acad Sci USA 86: 500–504
Plump AS, Smith JD, Hayek T et al. (1992) Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71: 343–353
Feingold KR (1989) Importance of small intestine in diabetic hypercholesterolemia. Diabetes 38: 141–145
Young NL, Lopez DR, McNamara DJ (1988) Contributions of absorbed dietary cholesterol and cholesterol synthesized in small intestine to hypercholesterolemia in diabetic rats. Diabetes 37: 1151–1156
Feingold KR, Zsigmond G, Lear SR, Moser AH (1986) Effect of food uptake on intestinal cholesterol synthesis in rats. Am J Physiol 251: G362-G369
Young NL, Saudek CD, Walters L, Lapeyrolerie J, Chang V (1982) Preventing hyperphagia normalizes 3-hydroxy-3-methylglutaryl-CoA reductase activity in small intestine and liver of diabetic rats. J Lipid Res 23: 831–838
Jiao S, Matsuzawa Y, Matsubara K et al. (1988) Increased activity of intestinal acyl-CoA: cholesterol acyltransferase in rats with streptozotocin-induced diabetes and restoration by insulin supplementation. Diabetes 37: 342–346
Matsubara K, Matsuzawa Y, Jiao S et al. (1988) Cholesterollowering effect of N-(α-methylbenzyl) linoleamide (melinamide) in cholesterol-fed diabetic rats. Atherosclerosis 72: 199–204
Redgrave TG, Callow MJ (1990) The effect of insulin deficiency on the metabolism of lipid emulsion models of triacylglycerol-rich lipoproteins in rats. Metabolism 39: 1–10
Bhattacharya S, Redgrave TG (1981) The content of apolipoprotein B in chylomicron particles. J Lipid Res 22: 820–828
Elovson J, Chatterton JE, Bell GT et al. (1988) Plasma very low density lipoproteins contain a single molecule of apolipoprotein B. J Lipid Res 29: 1461–1473
Davidson NO, Kollner ME, Glickman RM (1986) Apolipoprotein B synthesis in rat small intestine: regulation by dietary triglyceride and biliary lipid. J Lipid Res 27: 30–39
Black DD, Rower-Nutter PL (1990) Intestinal apolipoprotein synthesis in the newborn piglet. Pediatr Res 29: 32–38
Hayashi H, Fujimoto K, Cardell JA, Nutting DF, Bergstedt S, Tso P (1990) Fat feeding increases size but not number of chylomicrons produced by small intestine. Am J Physiol 259: G709-G719
Redgrave TG, Roberts DCK, West CE (1975) Separation of plasma lipoproteins by density gradient ultracentrifugation. Anal Biochem 65: 42–49
Schoefl GI (1968) The ultrastructure of chylomicra and of the particles in an artificial fat emulsion. Proc Roy Soc B 169: 147–152
Herbert PN, Schulman RS, Levy RI, Fredrickson DS (1973) Fractionation of the C-apoproteins from human plasma very low density lipoproteins. J Biol Chem 248: 4941–4946
Hardman DA, Kane JP (1986) Isolation and characterization of apolipoprotein B48. In: Segrest JP, Albers JJ (eds) Methods in enzymology, plasma lipoproteins part A, Vol 128. Harcourt Brace Jovanovich, Orlando San Diego New York Austin London Montreal Sydney Tokyo Toronto, pp 262–272
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage 14. Nature 227: 680–685
Zilversmit DB, Shea TM (1989) Quantitation of apo B-48 and apo B-100 by gel scanning or radio-iodination. J Lipid Res 30: 1639–1646
Miller KW, Small DM (1987) Structure of triglyceride-rich lipoprotein: an analysis of core and surface phases. In: Gotto AM Jr (ed) Plasma lipoproteins. Elsevier, Amsterdam New York Oxford, pp 1–75
Carlson LA (1963) Determination of serum triglycerides. J Atheroscl Res 3: 333–336
Zlatkis A, Zak B (1969) Study of a new cholesterol reagent. Anal Biochem 29: 143–148
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurements with the Folin phenol reagent. J Biol Chem 193: 265–275
Barlett GR (1959) Phosphorus assay in column chromatography. J Biol Chem 234: 466–468
Wilkinson L, Hill MA, Vang E (1992) SYSTAT: statistics, Version 5.2 edition. SYSTAT, Inc., Evanston
Redgrave TG, Ly HL, Quintao E, Ramberg CF, Boston RC (1993) Clearance from plasma of triacylglycerol and cholesteryl ester after intravenous injection of chylomicron-like lipid emulsions in rats and man. Biochem J 290: 843–847
Redgrave TG, Snibson DA (1977) Clearance of chylomicron triacylglycerol and cholesteryl ester from the plasma of streptozotocin-induced diabetic and hypercholesterolemic hypothyroid rats. Metabolism 26: 493–503
Mamo JCL, Elsegood CL, Umeda Y, Hirano T, Redgrave TG (1993) Effect of Probucol on plasma clearance and organ uptake of chylomicrons and VLDLs in normal and diabetic rats. Arterioscl Thromb 13: 231–239
Levy E, Shafrir E, Ziv E et al. (1985) Composition, removal and metabolic fate of chylomicrons derived from diabetic rats. Biochim Biophys Acta 834: 376–385
Zerbinatti CV, Oliveira HCF, Wechesler S, Quintao ECR (1991) Independent regulation of chylomicron lipolysis and particle removal rates: effects of insulin and thyroid hormones on the metabolism of artificial chylomicrons. Metabolism 40: 1122–1127
Tetsu E, Tsutomu H, Mamo JCL et al. (1993) Hyperlipidemia in streptozotocin-diabetic hamsters as a model for human insulin-deficient diabetes: comparison with streptozotocindiabetic rats. Metabolism
Staprans I, Pan X-M, Rapp JH, Feingold KR (1992) Chylomicron and chylomicron remnant metabolism in STZ-induced diabetic rats. Diabetes 41: 325–333
Kalogeris JJ, Story JA (1992) Lymph chylomicron composition and size are modified by level of intestinally infused cholesterol and triglyceride source in rats. J Nutr 122: 1045–1055
Li Q-T, Sawyer WH (1992) Effect of unesterified cholesterol on the compartmentation of a fluorescent cholesteryl ester in a lipoprotein-like lipid microemulsion. J Lipid Res 33: 503–512
Tso P, Drake DS, Black DD, Sabesin SM (1984) Evidence for separate pathways of chylomicron and very low-density lipoprotein assembly and transport by rat small intestine. Am J Physiol 247: G559-G610
Krause BR, Sloop CH, Castle CK, Roheim PS (1981) Mesenteric lymph apolipoproteins in control and ethinyl estradioltreated rats: a model for studying apolipoproteins of intestinal origin. J Lipid Res 22: 610–619
Nestel PJ, Fidge NH, Tan MH (1982) Increased lipoproteinremnant formation in chronic renal failure. New Engl J Med 307: 329–333
Cohn JS, McNamara JR, Cohn SD, Ordovas JM, Schaefer EJ (1988) Plasma apolipoprotein changes in the triglyceriderich lipoprotein fraction of human subjects fed a fat-rich meal. J Lipid Res 29: 925–936
Mamo JCL, Hirano T, Sainsbury A, Fitzgerald AK, Redgrave TG (1992) Hypertriglyceridemia is exacerbated by slow lipolysis of triacylglycerol-rich lipoproteins in fed but not fasted streptozotocin diabetic rats. Biochim Biophys Acta 1128: 132–138
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Martins, I.J., Sainsbury, A.J., Mamo, J.C.L. et al. Lipid and apolipoprotein B48 transport in mesenteric lymph and the effect of hyperphagia on the clearance of chylomicron-like emulsions in insulin-deficient rats. Diabetologia 37, 238–246 (1994). https://doi.org/10.1007/BF00398049
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00398049